Your browser doesn't support javascript.
loading
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Drilon, Alexander; Siena, Salvatore; Dziadziuszko, Rafal; Barlesi, Fabrice; Krebs, Matthew G; Shaw, Alice T; de Braud, Filippo; Rolfo, Christian; Ahn, Myung-Ju; Wolf, Jürgen; Seto, Takashi; Cho, Byoung Chul; Patel, Manish R; Chiu, Chao-Hua; John, Thomas; Goto, Koichi; Karapetis, Christos S; Arkenau, Hendrick-Tobias; Kim, Sang-We; Ohe, Yuichiro; Li, Yu-Chung; Chae, Young K; Chung, Christine H; Otterson, Gregory A; Murakami, Haruyasu; Lin, Chia-Chi; Tan, Daniel S W; Prenen, Hans; Riehl, Todd; Chow-Maneval, Edna; Simmons, Brian; Cui, Na; Johnson, Ann; Eng, Susan; Wilson, Timothy R; Doebele, Robert C.
Afiliación
  • Drilon A; Weill Cornell Medical College, New York, NY, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Siena S; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Dziadziuszko R; Institute of Cancer Sciences, Medical University of Gdansk, Gdansk, Poland.
  • Barlesi F; Aix Marseille University, INSERM, CNRS, CRCM, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
  • Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Shaw AT; Institute of Cancer Sciences, Massachusetts General Hospital, Boston, MA, USA.
  • de Braud F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, Università deli Studi di Milano, Milan, Italy.
  • Rolfo C; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Ahn MJ; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Wolf J; Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
  • Seto T; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Cho BC; Yonsei Cancer Center, Seoul, South Korea.
  • Patel MR; University of Minnesota, Department of Medicine, Minneapolis, MN, USA.
  • Chiu CH; Taipei Veterans General Hospital, Taipei, Taiwan.
  • John T; Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia.
  • Goto K; National Cancer Center Hospital East, Kashiwa, Japan.
  • Karapetis CS; Flinders Medical Centre and Flinders University, Adelaide, SA, Australia.
  • Arkenau HT; Sarah Cannon Research Institute and Cancer Institute University College London, London, UK.
  • Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Ohe Y; National Cancer Center Hospital, Tokyo, Japan.
  • Li YC; Hong Kong United Oncology Centre, Hong Kong Special Administrative Region, China.
  • Chae YK; Department of Medicine, Northwestern University, Chicago, IL, USA.
  • Chung CH; Moffitt Cancer Center, Tampa, FL, USA.
  • Otterson GA; Arthur G James Cancer Hospital and Richard J Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Murakami H; Shizuoka Cancer Center, Tokyo, Japan.
  • Lin CC; National Taiwan University Hospital, Taipei, Taiwan.
  • Tan DSW; National Cancer Centre, Singapore.
  • Prenen H; University Hospital Antwerp, Edegem, Belgium.
  • Riehl T; Genentech, South San Francisco, CA, USA.
  • Chow-Maneval E; Ignyta, San Diego, CA, USA.
  • Simmons B; Genentech, South San Francisco, CA, USA.
  • Cui N; Genentech, South San Francisco, CA, USA.
  • Johnson A; Ignyta, San Diego, CA, USA.
  • Eng S; Genentech, South San Francisco, CA, USA.
  • Wilson TR; Genentech, South San Francisco, CA, USA.
  • Doebele RC; School of Medicine, University of Colorado, Aurora, CO, USA. Electronic address: robert.doebele@cuanschutz.edu.
Lancet Oncol ; 21(2): 261-270, 2020 02.
Article en En | MEDLINE | ID: mdl-31838015
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Benzamidas / Proteínas Tirosina Quinasas / Biomarcadores de Tumor / Proteínas Proto-Oncogénicas / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Fusión Génica / Indazoles / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Benzamidas / Proteínas Tirosina Quinasas / Biomarcadores de Tumor / Proteínas Proto-Oncogénicas / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Fusión Génica / Indazoles / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos